Examples of using Fourth study in English and their translations into Hungarian
{-}
-
Medicine
-
Official
-
Colloquial
-
Ecclesiastic
-
Financial
-
Programming
-
Official/political
-
Computer
The fourth study was done in 302 patients with advanced neuroendocrine tumours of lung or gutorigin.
Presentation of the results of the third and fourth study visit and report submitted to the host partner;
The fourth study involved 731 patients who had not responded to at least one previous chemotherapy treatment;
Continuing with the theme of extensive uptake of appropriations, he added that the Budget Group wasproposing no longer to accept requests for fourth study group meetings.
The fourth study compared the effects of Evista with those of placebo in the treatment of osteoporosis in 7,705 women over four years.
The fourth study involved 226 women, and compared Hycamtin with paclitaxel(another anticancer medicine).
The fourth study compared the effects of Quintarix given at six, 10 and 14 weeks of age in 318.
A fourth study found no significant difference in the frequency of hot flashes between the ginseng and placebo group.
A fourth study also compared the effectiveness of adding Travatan to treatment with timolol(427 patients, six-month duration).
A fourth study was carried out with ProQuad(a vaccine that contains similar weakened viruses to those of M-M-RVAXPRO) given as two doses.
A fourth study in 1,620 babies was carried out with ProQuad(a vaccine that contains similar weakened viruses to those of M-M-RVaxPro).
In the fourth study in patients with the R117H mutation, no difference was seen between placebo and Kalydeco for children aged 6 years and above.
Fourth year: The fourth study year is time for advancing your competence in selected study modules and preparing yourself for working life challenges.
The fourth study compared the combination of Herceptin and anastrozole(an aromatase inhibitor) with anastrozole alone in 208 patients.
A fourth study on civil society engagement(best practices) is likely to be published around the time of the communication's adoption in July.
In the fourth study, the average reduction with Bydureon was 1.5 points after 26 weeks, compared with an average reduction of 1.3 points with insulin glargine.
The fourth study compared IONSYS to morphine given by injection into a vein, and looked at the number of patients who judged their pain relief as‘ good' or‘ excellent'.
A fourth study, involving 280 adults who had not responded to treatment with lamivudine, compared Viread alone with a combination treatment of Viread and emtricitabine.
The fourth study, involving 115 patients, looked at the effectiveness of 16 mg/kg Bridion in producing rapid reversal of the muscle relaxation using rocuronium.
The fourth study was done in 201 patients with hepatitis C virus(genotypes 2 or 3) who did not respond to previous treatment with interferon or whose infections came back.
The fourth study compared the effects of Quintarix given at six, 10 and 14 weeks of age in 318 infants who either had or had not received a hepatitis B vaccine at birth.
The fourth study showed that, after the second dose, the production of antibodies against mumps, and rubella was similar among babies who started vaccination at nine, 11 and 12 months.
In the fourth study, in lung cancer patients who had not responded to previous chemotherapy, the patients taking Tarceva survived for an average of 6.7 months, compared with 4.7 months for the patients taking placebo.
A fourth study involved approximately 85,000 adults over 65 year of age who had not previously been vaccinated with the 23-valent polysaccharide vaccine, and compared Prevenar 13 with placebo(a dummy treatment).
The fourth study showed no evidence of a higher risk of fatal and non-fatal self- harm(HR of 0.88; 95% CI: 0.52-1.49) in patients prescribed varenicline compared to patients prescribed NRT.
The fourth study provides an account of some significant international higher education conferences, conference volumes, which deal with the diversity of higher education, the emergence of various missions and institutional rankings.
The fourth study involving 324 patients compared the effects of Aubagio with interferon beta-1a(another treatment for MS) on the rate of treatment failure, by looking at the time until patients had their first relapse or permanently stopped their treatment.
The fourth study compared Multaq with amiodarone(another medicine used to prevent atrial fibrillation) in 504 patients and looked at the number of patients in whom atrial fibrillation came back or who had to stop treatment because it was causing side effects or not working.
The third and fourth studies looked at the effectiveness of laropiprant in reducing the flushing caused by nicotinic acid.